Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Microtrial With PLZ4-Coated Paclitaxel-Loaded Micelles (PPM) in Patients With Recurrent or Refractory Non-Myoinvasive Bladder Cancer

NCT06173349 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06173349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06173349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Microtrial With PLZ4-Coated Paclitaxel-Loaded Micelles (PPM) in Patients With Recurrent or Refractory Non-Myoinvasive Bladder Cancer
Lead sponsor
University of California, Davis
Phase
Phase 1
Overall status
Recruiting
Start date
November 22, 2023
Completion date
June 30, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent non-muscle invasive bladder carcinoma, stage 0a bladder cancer ajcc v8, stage 0is bladder cancer ajcc v8, stage i bladder cancer ajcc v8